Purification of Human Anti-TF (Thomsen-Friedenreich) and Anti-Tn Antibodies by Affinity Chromatography on Glycophorin A Derivatives and Characterization of the Antibodies by Microtiter Plate ELISA

Archivum Immunologiae et Therapiae Experimentalis

Volumn 46, Issue 2, 1998, Pages 69-77

  Duk, Maria ^a   Lisowska, Elwira ^a  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

Author keywords

Anti TF antibodies; Anti Tn antibodies, affinity chromatography; ELISA; Glycophorin; Thomsen Friedendreich (TF) antigen; Tn antigen

Indexed keywords

ANTIBODY; BETA GALACTOSYL(1 3) N ACETYLGALACTOSAMINE; BETA-GALACTOSYL(1-3)-N-ACETYLGALACTOSAMINE; DRUG DERIVATIVE; GLYCOPHORIN; TN ANTIGEN; TUMOR ANTIGEN;

AFFINITY CHROMATOGRAPHY; ANTIBODY SPECIFICITY; ARTICLE; BLOOD; CARBOHYDRATE ANALYSIS; CHEMISTRY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMAGGLUTINATION; HUMAN; IN VITRO STUDY; ISOLATION AND PURIFICATION; METHODOLOGY; MOLECULAR GENETICS;

ANTIBODIES; ANTIBODY SPECIFICITY; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; CARBOHYDRATE SEQUENCE; CHROMATOGRAPHY, AFFINITY; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLYCOPHORIN; HEMAGGLUTINATION; HUMANS; MOLECULAR SEQUENCE DATA;

EID: 0031603620     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. BLUMENFELD O. O., LALEZARI P., KHORSHIDI M., PUGLIA K. and FUKUDA M. (1992): 0-linked oligosaccharides of glycophorins A and B in erythrocytes of two individuals with the Tn polyagglutinability syndrome. Blood, 80, 2388-2395.
2. BRAY J., MACLEAN G. D., DUSEL F. J. and MCPHERSON T. A. (1982): Decreased levels of circulating lytic anti-T in the serum of patients with metastatic gastrointestinal cancer: a correlation with disease burden. Clin. Exp. Immunol., 47, 176-182.
3. CHEN Y., JAIN R. H., CHANDRASEKARAN E. V. and MATTA K. L. (1995): Use of sialylated or sulfated derivatives and acrylamide copolymers of Galβ1,3GalNAcα- and GalNAcα- to determine the specificities of blood group T- and Tn-specific lectins and the copolymers to measure anti-T and anti-Tn antibody levels in cancer patients. Glycoconjugate J., 12, 55-62
4. DAHLENBORG K., HULTMAN L., CARLSSON R. and JANSSON B. (1997): Human monoclonal antibodies specific for the tumor associated Thomsen-Friedenreich antigen. Int. J. Cancer, 70, 63-71.
5. DAHR W., UHLENBRUCK G., GUNSON H. H. and VAN DER HART G. (1975): Molecular basis of Tn polyagglutinability. Vox Sang., 29, 36-50.
6. DESAI P., UJJAINWALA L. H., CARLSTEDT S. C. and SPRINGER G. F. (1995): Anti-Thomsen-Friedenreich (T) antibody-based ELISA and its application to human breast carcinoma detection. J. Immunol. Methods, 188, 175-185.
7. DUK M., LISOWSKA E., Wu J. H. and Wu A. M. (1994): The biotin/avidin-mediated microtiter plate lectin assay with the use of chemically modified glycoprotein ligand. Anal. Biochem., 221, 266-272.
8. DUK M., STEUDEN I., DUŚ D., RADZIKOWSKI C. and LISOWSKA E. (1992): Application of chemically desialylated and degalactosylated human glycophorin for induction and characterization of anti-Tn monoclonal antibodies. Glycoconjugate J., 9, 148-153.
9. JANSSON B. and BORREBAECK C. A. K. (1992): The human repertoire of antibody specificities against Thomsen-Friedenreich and Tn carcinoma-associated antigens as defined by human monoclonal antibodies. Cancer Immunol. Immunother., 34, 294-298.
10. KANIA J., UHLENBRUCK G., JANSSEN E., KLEIN P. J. and VIERBUCHEN M. (1980): Isolation, characterization and implications of anti-TF (Thomsen-Friedenreich) agglutinins from different sources. Immunobiology, 157, 154-168.
11. KIM Y. D., PARAKASH U., WEBER G. F. and MARGIE M. (1979): Nature of human serum blood group T antibodies. Immunol. Commun., 8, 397-406.
12. KJELDSEN T., HAKOMORI S., SPRINGER G. F., DESAI P., HARRIS T. and CLAUSEN H. (1989): Coexpression of sialosyl-Tn (Neu-Acα2-6GalNAcα1-O-Ser/Thr) and Tn (GalNAcα1-O-Ser/Thr) blood group antigens on Tn erythrocytes. Vox Sang., 57, 81-87.
13. KOCHANOWSKA I. E., RAPAK A. and SZEWCZUK A. (1994): Effect of pretreatment of wells in polystyrene plates on adsorption of some human serum proteins. Arch. Immunol. Ther. Exp., 42, 135-139.
14. KROTKIEWSKI H. (1988): The structure of glycophorins of animal erythrocytes. Glycoconjugate J., 5, 35-48.
15. KROTKIEWSKI H., DUK M., SYPER D., LIS H., SHARON N. and LISOWSKA E. (1997): Blood group MN-dependent difference in degree of galactosylation of O-glycans of glycophorin A is restricted to the GalNAc residues located on amino acid residues 2-4 of the glycophorin polypeptide chain. FEBS Lett., 406, 296-300.
16. KURTENKOV O., KLAAMAS K. and MILJUKHINA L. (1995): The lower level of natural anti-Thomsen-Friedenreich antigen (TFA) agglutinins in sera of patients with gastric cancer related to AB0(H) blood-group phenotype. Int. J. Cancer, 60, 781-785.
17. LAEMMLI U. K. (1965): Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680-685.
18. LISOWSKA E. (1988): Antigenic properties of human erythrocyte glycophorins. In Wu A. M. (ed.): The molecular immunology of complex carbohydrates. Plenum Press, New York, London, 265-315.
19. LISOWSKA E. (1995): Tn antigens and their significance in oncology. Acta Biochim. Pol., 42, 11-18.
20. LISOWSKA E., MESSETER L., DUK M., CZERWIŃSKI M. and LUNDBLAD A. (1987): A monoclonal anti-glycophorin A antibody recognizing the blood group M determinant: studies on the subspecificity. Mol. Immunol., 24, 605-613.
21. MIKULSKA J., GORCZYCA W. and LISOWSKI J. (1996): Interaction of human erythrocyte glycophorin with immunoglobulins G. Arch. Immunol. Ther. Exp., 44, 27-32.
22. MYLLYLA G., FURUHJELM U., NORDLING S., PIKKOLA A., TIPPETT P., GAVIN J. and SANGER R. (1971): Presistent mixed-field polyagglutinability: electrokinetic and serological aspects. Vox Sang., 20, 7-23.
23. SMITH P. K., KROHN R. I., HERMANSON G. T., MALLIA A. K., GARTNER F. H., PROVENZANO M. D., FUJIMOTO E. K., GOEKE N. M., OLSON B. J. and KLENK D. C. (1985): Measurement of protein using bicinchoninic acid. Anal. Biochem., 150, 76-85.
24. SPRINGER G. F. (1984): T and Tn, general carcinoma markers. Science, 224, 1198-1206.
25. SPRINGER G. F. and DESAI P. R. (1985): Tn epitopes, immunoreactive with ordinary anti-Tn human antibodies, on normal, desialylated human erythrocytes and on Thomsen-Friedenreich antigen isolated therefrom. Mol. Immunol., 22, 1303-1310.
26. STEUDEN I., DUK M., CZERWIŃSKI M., RADZIKOWSKI C. and LISOWSKA E. (1985): The monoclonal antibody, anti-asialoglycophorin A from human erythrocytes, specific for β-D-Gal-1-3-α-D-GalNAc- chains (Thomsen-Friedenreich receptors). Glycoconjugate J., 2, 303-314.
27. TETTAMANTI G. and PIGMAN W. (1968): Purification and characterization of bovine and ovine submaxillary mucins. Arch. Biochem. Biophys., 124, 41-50.
28. THATCHER N., HASHMI K., CHANG J., SWINDELL R. and CROWTHER D. (1980): Anti-T antibody in malignant melanoma patients. Cancer, 46, 1378-1382.
29. UHLENBRUCK G. (1981): The Thomsen-Friedenreich (TF) receptor - an old history with new mystery. Immunol. Commun., 10, 251-264.
30. WOLF F. M., KOERNER U., KLUMPP B. and SCHUMACHER K. (1987): Characterization of Thomsen-Friedenreich antibody subpopulations from normal human serum. Tumor Biol. 8, 264-272.
31. WU A. M., DUK M., LIN M. C., BROADBERRY R. E. and LISOWSKA E. (1995): Identification of variant glycophorins of human erythrocytes by lectinoblotting. Application to MiIII variant which is relatively frequent in Taiwanese population. Transfusion, 35, 571-576.